Sanofi, GSK ink deal with EU for 300 million COVID-19 vaccine doses
Upfront funding will be used to scale-up manufacturing
Read More
Author: Lucy Parsons
Bristol Myers Squibb’s Opdivo shows benefit in oesophageal cancers
Data presented at 2020 ESMO virtual congress
Read More
GSK’s Zejula and AZ’s Lynparza leap toward broader EU approval
Both PARP inhibitors receive positive opinions from CHMP
Read More
Roche acquires Irish biotech firm Inflazome
Swiss pharma company to acquire biotech for $449m (€380m)
Read More
UK’s chief medical officers upgrade coronavirus alert level
Decision made following review of rising COVID-19 cases
Read More
